PubMed 11. Mendonca N, Manageiro V, Bonnet R, Canica M: Biochemical characterization of SHV-55, an extended-Spectrum class A β-Lactamase from Klebsiella #Baf-A1 manufacturer randurls[1|1|,|CHEM1|]# pneumoniae . Antimicrob Agents Chemother 2008, 52:1897–8.PubMedCrossRef 12. Huletsky A, Knox JR, Levesque RC: Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type β-lactamases probed
by site-directed mutagenesis and three-dimensional modeling. J Biol Chem 1993, 15:3690–97. 13. Kalp M, Bethel CR, Bonomo RA, Carey PR: Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are “”hypersusceptible”" to mechanism-based inhibitors. Biochemistry 2009, 48:9912–20.PubMedCrossRef 14. Matagne A, Lamotte-Brasseur J, Frere JM: Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem J 1998, 330:581–98.PubMed 15. Barlow M, Hall BG: Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.
Genetics 2002, 160:823–32.PubMed 16. Reynolds KA, Thomson JM, Corbett KD, Bethel CR, Berger JM, Kirsch JF, Bonomo RA, Handel TM: Structural and Computational Characterization of the SHV-1 β-Lactamase-β-Lactamase inhibitor protein interface. J Biol Chem 2006, 281:5–532674. 17. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing; 15 th informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, Pa; 2006. 18. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing; 19 th informational supplement. M100-S19. Clinical and Laboratory Selleck VX-680 Standards Institute, Wayne, Pa; 2009.
19. Zheng L, Baumann U, Reymond JL: An efficient one-step site-directed and site saturation mutagenesis Dichloromethane dehalogenase protocol. Nucleic Acid Res 2004.,32(14): 20. Mendonca N, Manageiro V, Robin F, Salgado MJ, Ferreira E, Caniça M, Bonnet R: The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition. Antimicrob Agents Chemother 2008, 52:1806–11.PubMedCrossRef 21. Li X-Z, Mehrotra M, Ghimire S, Adewoye L: β-Lactam resistance and β-lactamases in bacteria of animal origin. Vet Microbiol 2007, 121:197–214.PubMedCrossRef 22. Haggman S, Lofdahl S, Burman LG: An allelic variants of the chromosomal gene for class A β-lactamase K2, specific for Klebsiella pnemoniae , is the ancestor of SHV-1. Antimicrob Agents Chemother 1997, 41:2705–09. 23. Nicolas MH, Jarlier V, Honore N, Philippon A, Cole ST: Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae . Antimicrob Agents Chemother 1989, 33:2096–100.PubMed Authors’ contributions NR, SBC and MKS carried out cloning expression and western blot, SP contributed in enzyme kinetics, JCJ did Simulation docking experiment. YJY and HSY provided guidance and helped coordination.